Agile Therapeutics Inc (AGRX) - News Archive

Agile Therapeutics Expands Women s Health/Contraceptive Portfolio with Exeltis USA MergerAgile Therapeutics, a leading pharmaceutical company in the women s health sector, has announced its merger with Insud Pharmas US...

Furthermore, Agile Therapeutics corporate customers have recorded a significant increase in their cost of revenue by 6.84% in the third quarter of 2023 year on year, with sequential costs of revenue growing by 1.9%. Mea...

Agile Therapeutics Inc: Eliminating Debt and Focused on Business Plan ExecutionAgile Therapeutics Inc, a pharmaceutical company specializing in women’s healthcare, has announced the successful completion of its debt rep...

PRINCETON, N.J., Feb. 22, 2024 - Agile Therapeutics, Inc. (Nasdaq: AGRX), a prominent women s healthcare company, recently made an exciting announcement regarding its entry into a definitive agreement for the immediate...

Agile Therapeutics Granted Extension by Nasdaq Hearings Panel and Provides Performance UpdateAgile Therapeutics, a leading women s healthcare company focusing on the development and commercialization of innovative healt...

The Biden-Harris Administration has recently announced new guidance that aims to expand access to all FDA-approved contraceptives without cost. This development has significant implications for the pharmaceutical indust...